BARCLAYS PLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$324
-8.5%
9,521
+3.7%
0.00%
Q2 2023$354
+8750.0%
9,179
+9079.0%
0.00%
Q1 2023$4
-99.9%
100
-47.6%
0.00%
Q1 2022$6,000
+500.0%
191
+377.5%
0.00%
Q2 2021$1,000
-66.7%
40
-78.0%
0.00%
Q1 2021$3,000
+200.0%
182
+111.6%
0.00%
Q4 2020$1,000
-50.0%
86
-47.2%
0.00%
Q4 2019$2,000
-33.3%
163
-57.1%
0.00%
Q3 2019$3,000380
+18900.0%
0.00%
Q1 2019$0
-100.0%
2
-99.9%
0.00%
Q4 2018$24,0003,7270.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders